GP2015 as a promising therapy for rheumatoid arthritis

Fitton, J, Giollo, A and Buch, MH orcid.org/0000-0002-8962-5642 (2018) GP2015 as a promising therapy for rheumatoid arthritis. Expert Opinion on Biological Therapy, 18 (4). pp. 477-481. ISSN 1471-2598

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2018, Informa UK Limited, trading as Taylor & Francis Group. This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Biological Therapy on 20 March 2018, available online: https://doi.org/10.1080/14712598.2018.1452909
Keywords: Biosimilar; etanercept; GP2015; immunogenicity; pharmacodynamics; pharmacokinetics; rheumatoid arthritis; safety; TNF inhibitor
Dates:
  • Published: 20 March 2018
  • Accepted: 12 March 2018
  • Published (online): 20 March 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 Apr 2018 14:41
Last Modified: 20 Mar 2019 01:39
Status: Published
Publisher: Taylor & Francis
Identification Number: https://doi.org/10.1080/14712598.2018.1452909

Share / Export

Statistics